{"name":"Acepodia Biotech, Inc.","slug":"acepodia-biotech-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"ACE1702","genericName":"ACE1702","slug":"ace1702","indication":"Other","status":"phase_1"},{"name":"ACE1831","genericName":"ACE1831","slug":"ace1831","indication":"Other","status":"phase_1"},{"name":"ACE2016","genericName":"ACE2016","slug":"ace2016","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"ACE1702","genericName":"ACE1702","slug":"ace1702","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ACE1831","genericName":"ACE1831","slug":"ace1831","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ACE2016","genericName":"ACE2016","slug":"ace2016","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikwJBVV95cUxNc1lsTmVGYmFzSGkzRXlVX2RMeDI2UlQ0VVJBVkhYMkQ1VlpaMFNCX3gtdzBwZEU5UWtUbWNPWmxhMm5jQ3AyMWtMMXhkVW9RSlM2bTNzVy1SdUt6Vmp0Wjk3T0tvUGZHQktEc1B0aTBBbUNfelU4XzFoOHZWVEdrVFpNYklZbFZNQWFDUlFhbVFaaDdYVE03VlNvdk9VczhYY2Q2Ul9KX0F3c3RKQk1QZVQxa3BuOEJOMnQ2Q1lwc3hLYkc5UEtSWm1wTVNHMVpaQ2Y1SmQ3dGljYS1aWjNIWVotRUI1T1lTLUZMb3ROenV5T2ZPOVl5cnVBV19CbTNabnRhOGQzSXhhY1pDWnBXOGFabw?oc=5","date":"2026-03-21","type":"trial","source":"Barchart.com","summary":"HER2 Positive Gastric Cancer Clinical Trial Pipeline Accelerates as 20+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - Barchart.com","headline":"HER2 Positive Gastric Cancer Clinical Trial Pipeline Accelerates as 20+ Pharma Companies Rigorously Develop Drugs for Ma","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiqgJBVV95cUxNNmpfY0ZVcmRyXzc3ZHRzbE1nR0Yxa18zcnhwanBxWGhjUmdXNVotdzJna1ZqQnpKRUVtMFlPLUpFek9uUTNzRldaeDN4bWpQTnliTWNIWmU5a1VuR2paNWZGQUc4TG5aY1M1RE95UTNSdm9LSXFqc1lXXzlCRGhKdE5zQl8tX2FVRmlPZTJvNjJIZGVGeFduTTZ1WnpPZ21xbTY1WUtoNjBheXotUExvbjdqbmxGV0ZwRFV2MzNfRTdTRUJLcmw3UjlNWFpwcVNQeUx1Y2x1WTlqdTNoYVFISWVxQTE1bVBwN0lVVGFXeHhicmdFUDhKRF9hQldJTGRYcDdNcmZtUnlpM2ZJeUI1UVlHQVNSZWZYT05BUTRGMU5YVnpvb2ZweldR?oc=5","date":"2026-01-09","type":"deal","source":"Business Wire","summary":"Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C) - Business Wire","headline":"Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwJBVV95cUxPa1RvclY0b3RYZGJDTFEwdmNLd1pmUmNVcndXaHlBR2xPU0JUUUNkNjFPcUdOVmRhdkdPTEtGSW5qV2ZJMHdxR2J3N0RON1BoU2cxS1lpQ0JJUDJJaU5JelZZNTZDRjhQdGZJYVJQUmd4Wms2SEtyMDNJa0d1alloRDNIak9HZ2dnRzU2Qk00QV90Q1lyNThtdDZiYXNkUVZYUXRKbE11QjZOUGdPYUNzbzhoZjNXNngwTEkxUFJfWjB1M2d6cUdJTWRBckJvM1JYWUt4NG1xMXM1NndObjhPVy11bHZYS29WSTRKdmJybHJfLWtiM2NOemwtM0NORF9CTnE0?oc=5","date":"2025-01-07","type":"pipeline","source":"Business Wire","summary":"Biocytogen and Acepodia Join Forces to Advance Bispecific Antibody and Dual-Payload ADCs for Treating Complex Tumors - Business Wire","headline":"Biocytogen and Acepodia Join Forces to Advance Bispecific Antibody and Dual-Payload ADCs for Treating Complex Tumors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUkFVX3lxTE1JbDFQR1V2ZlRHR19qaWlHZEl6cnhyWDNsNjQ0T2RRUHd1UFlZR0U5MTUxRnM0ZFg1Uld0Y3VEdFdfZ0RxcVN4WjQ5THlYN2xqMEE?oc=5","date":"2024-09-13","type":"pipeline","source":"The Pharma Letter","summary":"Acepodia - The Pharma Letter","headline":"Acepodia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxPLUtTTGxhcWpTdkUyVC1sc3MycVY2OW1kblplb3ZRNlFTN19SalFwaWE0VzVwYllBX0lDU1VvREhVRXN6VnllVVAzTFJveUp6Nl8yTTl0SV9HSS1CbnZlbmRaZ0k0ZmJMQXRNRkhZclljSE93eVAwcnJVQll5ZE5nWkpoWUhvTHpmU0oxM0E1TWwwSDk4VFVKdExoOUcwekdITGc?oc=5","date":"2024-09-04","type":"deal","source":"The Pharma Letter","summary":"Acepodia partners with Pfizer to advance cell therapies - The Pharma Letter","headline":"Acepodia partners with Pfizer to advance cell therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxPZHZiR2w2Skx1U1l1Qnl6UHVsVTRWY1pnOGpwTk5BM1BxSTRXcE1ua2s2ZmwxMnhRbTJBRVRWNnFPNnNNUllSXzBhVEpUVG5wbDYwRlRhbmRocE5KMnItVUtfQm9PSXVuMUxUZjZWaFNmVTR3TG45bGhaQXJkcy1uc1g4NXdMWlBsYmk4UmcybWxvUFg3NmRFZHV2RnM4MC11QlZUY0NiNm9XOFFtWURGR0l5d3VMaWFtU0E?oc=5","date":"2024-09-03","type":"pipeline","source":"Fierce Biotech","summary":"Acepodia and Pfizer Ignite click together to advance chemistry-based cell therapies - Fierce Biotech","headline":"Acepodia and Pfizer Ignite click together to advance chemistry-based cell therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxQdDQ4SHRpZlZyZG13TzZHc210ZnBmSE8wSkVqdFJ2amFuZ3pVSGVzNTRqaTRUNktYQjhFYS1aZ2IzQTkxSUU3Nzh4UV9lU3VPX2czSXdhRFBJdjJnRGJmSEpJRjluNy1rWnJFT2oyU09DcWtwUXpjMGF4WUxwcWtONlIyZGphUDVvUGdLUDEwZnVGQ2RiUTh6U1U3Q0N4NzUxcDdKVVRTbk5XMjFjV2FrQkloSXRZX1Jpek5R?oc=5","date":"2023-09-18","type":"pipeline","source":"Fierce Biotech","summary":"Nobel laureate Carolyn Bertozzi joins Acepodia as biotech aims to transform cancer cell therapy - Fierce Biotech","headline":"Nobel laureate Carolyn Bertozzi joins Acepodia as biotech aims to transform cancer cell therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxQaktvM2xicmc5bWVzemZRLVU0RXU4S0xKY0p2bUJqdEp6Y09yd19vTEwtTTBPVl82X05hWUdxSGpmMGdGSVItbHdsWnY2UDRYczMyQ0U0dFd1eGo1Skl5bEdOZmppX05qLXZVOWx1R3h1OWpjdnBYNnNrR0dnZHJfQlBRRktJM0ItVW96U3VERGM4Q0xnbnozajVQNlR0SHJ3SHNsd3RYeENqUQ?oc=5","date":"2023-06-06","type":"pipeline","source":"The Business Journals","summary":"East Bay drug maker Acepodia raises $100M as it preps for overseas IPO - The Business Journals","headline":"East Bay drug maker Acepodia raises $100M as it preps for overseas IPO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxQTkZnN0czZzNoLVZBZlk3UF90TjZiUDVJaGF2VTk2cjFYaTFOR1lRZXlyZi1CX09JOE9qZDdIbEpCQWRad0xNU3ZyNHV1Vk9mNUlMV0IyYzVzMzlVVFQtUGN5N2VkdjFjcGtvaXh5dk5GQ2szcUc0c2s0VkJXeF9UZWEwLWxEM3h5cDA1c211T3E1Q0RuaWYwb2pGM1owM2l4UFA0bGE0NWJUS1ZiR29RdUZ6ak1BU1d3Q0VYbFMySHI?oc=5","date":"2021-05-11","type":"pipeline","source":"Fierce Biotech","summary":"AbbVie oncology exec Graef jumps ship for natural killer cell biotech Acepodia - Fierce Biotech","headline":"AbbVie oncology exec Graef jumps ship for natural killer cell biotech Acepodia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6wFBVV95cUxNZV9MZlY0X3FmY01nbklmTEZyMzBEcHlVRDNvVFJkazBQbjhYc0ozbjc0VFFScERYN2psNVNnU2I2ZExQNmdrMWJvYkNPamZ6WDBqQ1BEbFA3MWVXRHVTNk9CTHBGOWJURkFOUzRfTHVUSUxoV0RLcXJ4WnBLdjZfOU90bkN4Tkd4MlJDVV9GVWtxY05OYzlObFJ5bTlNTXh2SllsWDluRU50aUF3TmdWVWUwLXo4QkhJLXRVdVhoQWRiMHZpQnlJVEtKZDhjU1FxNnZ6NGhBUXBxMVNfM0RzelRKS3NtVThIdXNJ?oc=5","date":"2020-09-01","type":"pipeline","source":"globenewswire.com","summary":"Acepodia Strengthens Management Team with Appointments of Biotech Industry Veterans - globenewswire.com","headline":"Acepodia Strengthens Management Team with Appointments of Biotech Industry Veterans","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"phase_1":3},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}